Stay updated on Upadacitinib in RA: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib in RA: Safety & Efficacy Clinical Trial page.

Latest updates to the Upadacitinib in RA: Safety & Efficacy Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedA new site revision label, Revision: v3.6.4, was added, and several topics/labels (including Rheumatoid arthritis and MedlinePlus Genetics) as well as an older revision label (Revision: v3.6.3) were removed from the page’s navigation or help sections.SummaryDifference0.1%

- Check17 days agoChange DetectedRheumatoid arthritis is now listed as a topic on the page. MedlinePlus Genetics is added as a related topic, expanding contextual links for RA and genetics information.SummaryDifference0.1%

- Check24 days agoChange DetectedThe page no longer displays the condition Rheumatoid arthritis and the related topics section, including the MedlinePlus Genetics link, reducing the contextual content and external resources on the study details page.SummaryDifference0.1%

- Check31 days agoChange DetectedThe IPD sharing documentation has been updated to Revision v3.6.3, replacing the prior v3.6.2. This reflects an administrative update to the data-sharing materials for the study.SummaryDifference0.0%

- Check38 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2. This indicates a minor version update to the page.SummaryDifference0.0%

- Check52 days agoChange DetectedNew user-help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the page now states that the study is no longer enrolling participants, with a minor formatting adjustment to the Intervention/Treatment heading.SummaryDifference0.2%

Stay in the know with updates to Upadacitinib in RA: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib in RA: Safety & Efficacy Clinical Trial page.